GRANULES
Granules India Ltd Trend AnalysisOne of the global leaders in manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.
Fundamentally sound with good ROCE & ROE of around 19%
Available at fair value with a forward PE of approx 7.5 whereas Sector PE is at 25.5
Debt to Equity is 0.40 due to capacity expansion.
Highest ever operating profit in FY 2022-23
Technically price is near trendline support, expecting break of trendline support towards 250 levels according to the falling wedge pattern highlighted.
Accumulate around 250 levels in the green zone for the following targets:
Short term target @ 400 (60% ROI with 6:1 R:R)
Mid term target @ 525 (110% ROI with 11:1 R:R)
Long term target @ 650 (160% ROI with 16:1 R:R)
Stop Loss below 225 (Optional)
Do your own due diligence before taking any action.
Peace!!
Granules Buy Idea 16 May 2023As per my analysis 297.75 is resistance for $NSE:GRANULES. If any 45min candle closed above level of 297.75, we can make buy entry at 298 with stop loss of 290 (only 08 points).
My expected upside target would be 304 & 318. This could be a low risk and high reward idea.
Note: This is my personal analysis, only to learn stock market behavior. Thanks.
#GRANULES Looking good for tomorrow#GRANULES... ✅▶️
Intraday as well as swing trade
All levels given in charts ...
IF good potential seen then we work in options also
if activate then possible a huge movement Keep eye on this ...
We take trade only when it activates...
Possible to give good target
TRADING FACTS
#IPCALAB #MOREPENLAB #DRREDDY #LAURUSLABS #DIVISLABS #AUROPHARMA#IPCALAB
NSE: IPCALAB
CMP: 864
TP: 980
SL: 840
TF: <6m
RR > ~4.5 times
Return > 13%
THYROCARE CNXPHARMA LUPIN SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE APOLLOHOSP FORTIS AARTIDRUGS ZYDUSWELL MAXHEALTH BAJAJHCARE
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia
#LALPATHLAB #MOREPENLAB #IPCALAB #DIVISLAB #VIMTALAB #LAURUSLABS#LALPATHLAB
NSE: LALPATHLAB
CMP: 2345
TP: 3075
SL: 2100
TF: <6m
RR > ~3 times
Return > 30%
THYROCARE CNXPHARMA LUPIN SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE APOLLOHOSP FORTIS AARTIDRUGS ZYDUSWELL MAXHEALTH BAJAJHCARE
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
#BIOCON #LUPIN #DIVISLAB #ALKEM #IPCALAB #GRANULES #AUROPHARMA#BIOCON
NSE: BIOCON
CMP: 267
TP: 320
SL: 250
TF: <6m
RR > 4 times
Return > 20%
THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia
#GLENMARK #SANOFI #PFIZER #BPLPHARMA #MARKSANS #BIOCON #GRANULES#GLENMARK
NSE: GLENMARK
CMP: 440
TP: 515
SL: 400
TF: <6m
RR > 2 times
Return > 17%
THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia
#aplltd #alembic #cipla #lauruslabs #biocon #granules #lupin #it#APLLTD
NSE:APLLTD
NSE:APLLTD
CMP: 725
Target: 815
SL: 700
RR > 3
TF < 3 months
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia
GRANULES Bounced off demand zone wait for breakoutGRANULES
BUY ABOVE - 319 (If sustains)
THE CHART IS SELF EXPLANATORY.
Please LIKE, COMMENT and SHARE to motivate and support me. I'll keep on posting new ideas on Indices & Stocks. Be sure to follow so that you don't miss any good trades that might have been rewarding.
Any comments and critiques will be appreciated even if it's of opposite view as a trader can also be right so many times.